In the modern view of selective drug delivery of bioactive molecules, the attention is moving onto the setup of the perfect carrier more than in the optimization of the active compound. In this respect, virus-like particles constitute bioinspired nanodevices with the intrinsic ability to transport a large class of molecules, ranging from smart drugs to small interfering RNAs. In this work, we demonstrate the efficacy of a novel construct obtained by fusing a self-assembling protein from the human Rotavirus A, VP6, with the Small Ubiquitin Modifier domain, which maintains the ability to form nanoparticles and nanotubes and is able to be used as a drug carrier, even without specific targeting epitopes. The high expression and purification yield, combined with low toxicity of the empty particles, clearly indicate a good candidate for future studies of selective drug delivery. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 2018.
Original languageEnglish
Pages (from-to)N/A-N/A
JournalBiotechnology Progress
Publication statusPublished - 2019


  • Biotechnology
  • innovative biotechnologies
  • personalized medicine
  • targeted therapy
  • virus-like particles


Dive into the research topics of 'A protein chimera self-assembling unit for drug delivery'. Together they form a unique fingerprint.

Cite this